全文获取类型
收费全文 | 4982篇 |
免费 | 505篇 |
国内免费 | 27篇 |
专业分类
耳鼻咽喉 | 43篇 |
儿科学 | 133篇 |
妇产科学 | 138篇 |
基础医学 | 559篇 |
口腔科学 | 90篇 |
临床医学 | 675篇 |
内科学 | 1023篇 |
皮肤病学 | 129篇 |
神经病学 | 266篇 |
特种医学 | 310篇 |
外国民族医学 | 1篇 |
外科学 | 820篇 |
综合类 | 170篇 |
现状与发展 | 30篇 |
一般理论 | 1篇 |
预防医学 | 352篇 |
眼科学 | 66篇 |
药学 | 261篇 |
中国医学 | 8篇 |
肿瘤学 | 439篇 |
出版年
2024年 | 15篇 |
2023年 | 203篇 |
2022年 | 53篇 |
2021年 | 91篇 |
2020年 | 107篇 |
2019年 | 79篇 |
2018年 | 164篇 |
2017年 | 127篇 |
2016年 | 125篇 |
2015年 | 133篇 |
2014年 | 196篇 |
2013年 | 211篇 |
2012年 | 265篇 |
2011年 | 306篇 |
2010年 | 224篇 |
2009年 | 217篇 |
2008年 | 220篇 |
2007年 | 252篇 |
2006年 | 193篇 |
2005年 | 194篇 |
2004年 | 185篇 |
2003年 | 198篇 |
2002年 | 184篇 |
2001年 | 123篇 |
2000年 | 98篇 |
1999年 | 104篇 |
1998年 | 81篇 |
1997年 | 82篇 |
1996年 | 90篇 |
1995年 | 74篇 |
1994年 | 61篇 |
1993年 | 63篇 |
1992年 | 61篇 |
1991年 | 68篇 |
1990年 | 63篇 |
1989年 | 67篇 |
1988年 | 69篇 |
1987年 | 53篇 |
1986年 | 50篇 |
1985年 | 36篇 |
1984年 | 34篇 |
1983年 | 20篇 |
1982年 | 21篇 |
1981年 | 18篇 |
1980年 | 23篇 |
1978年 | 17篇 |
1976年 | 22篇 |
1975年 | 26篇 |
1971年 | 17篇 |
1966年 | 16篇 |
排序方式: 共有5514条查询结果,搜索用时 156 毫秒
91.
应用改进的眼震图检查先天性眼球震颤 总被引:2,自引:0,他引:2
目的评价改进后的眼震图对先天性眼球震颤波形的分析,为其手术治疗提供较为精确的量化标准.方法改进电生理仪的视网膜电图(EOG)程序,分别记录68例患者33cm原在位、右5°、10°、15°、20°,左5°、10°、15°、20°,3m原在位及闭眼的波形,并对其中28例手术患者术前和术后的眼震图进行比较.结果68例患者中,跳动型48例,其中水平跳动46例,垂直跳动2例;水平钟摆型20例.跳动型中,有代偿头位的40例,钟摆型无明显代偿头位.28例手术患者中,水平跳动型26例,水平钟摆型2例.26例跳动型患者均有中间位和代偿头位.术后20例代偿头位消失,6例代偿头位在左5°~10°.按震频、振幅、震强的分组中,处于中等震频、振幅、震强范围内的多见.结论改进的眼震图可以对眼震的振幅、震频、震强、中间位进行量化的检测,从而指导其治疗. 相似文献
92.
Zhang JD Cao YB Xu Z Sun HH An MM Yan L Chen HS Gao PH Wang Y Jia XM Jiang YY 《第二军医大学学报》2006,27(6):664-664
Antifungal activity of natural products is being studied widely. Saponins are known to be antifungal and antibacterial. We have isolated eight steroid saponins from Tribulus terrestris L. , namely TTS-8, TTS-9, TTS-10, TTS-11, TTS-12, TTS-13, TTS-14 and TTS-15. TTS-12 and TTS-15 were identified as tigogenin-3-O-β-D-xylopyranosyl(1→ 2)-[-β-D-xylopyranosyl( 1 → 3 ) 3-β- D-glucopyranosyl ( 1 → 4 )- 1- α-L-rhamnopyranosyl ( 1 → 2 ) 3-β-D-galactopyranoside and tigogenin-3-O-β-D-glucopyranpyranosyl(1→2)-[-β-D-xylopyranosyl(1→ 3)3-β-D-glucopyranosyl(1→4)-β-D-galactopyranoside, respectively. The in vitro antifungal activities of the eight saponins against six fluconazole-resistant yeasts, Candida albicans, Candida glabrata, Candida para psilosis , Candida tropicalis , Candida krusei , and Cryptococcus neo f ormans were studied using microbroth dilution assay. The results showed that TTS-12 and TTS-15 were very effective against several pathogenic candidal species and C. neoformans in vitro. It is noteworthy that TTS-12 and TTS-15 were very active against fluconazole-resistant C. albicans (MIC80 = 4.4, 9.4 mg/ml), C. neoformans (MIC80 =10.7, 18.7 mg/ml) and inherently resistant C. krusei (MIC80 =8.8, 18.4 mg/ml). So in vivo activity of TTS-12 in a vaginal infection model with fluconazole-resistant C. albicans was studied in particular. Our studies revealed TTS-12 also showed in vivo activities against fluconazole-resistant yeasts. In conclusion, steroid saponins TTS-12 and TTS-15 from Tribulus terrestris L. have significant in vitro antifungal activity against fluconazole-resistant fungi, especially TTS-12 also showed in vivo activity against fluconazole-resistant C. albicans. 相似文献
93.
Francis Giles Srdan Verstovsek Deborah Thomas Stanton Gerson Jorge Cortes Stefan Faderl Alessandra Ferrajoli Farhad Ravandi Steven Kornblau Guillermo Garcia-Manero Elias Jabbour Susan O'Brien Verena Karsten Ann Cahill Karen Yee Maher Albitar Mario Sznol Hagop Kantarjian 《Clinical cancer research》2005,11(21):7817-7824
PURPOSE: Cloretazine (VNP40101M) is a novel sulfonylhydrazine alkylating agent with significant antileukemia activity. A phase I study of cloretazine combined with cytarabine (1-beta-d-arabinofuranosylcytosine, ara-C) was conducted in patients with refractory disease. DESIGN: Ara-C was given i.v. at a fixed dose of 1.5 gm/m(2)/d by continuous infusion for 4 days (patients ages <65 years at time of diagnosis) or 3 days (patients ages > or =65 years). Cloretazine was given i.v. over 15 to 60 minutes on day 2 at a starting dose of 200 mg/m(2), with escalation in 100 mg/m(2) increments in cohorts of three to six patients until a maximum tolerated dose was established. The DNA repair enzyme O(6)-alkylguanine DNA alkyltransferase (AGT) was measured at baseline. RESULTS: Forty patients, including 32 with acute myeloid leukemia, received 47 courses of treatment. Complete responses were seen at cloretazine dose levels of > or =400 mg/m(2) in 10 of 37 (27%) evaluable patients, and in this patient subset, AGT activity was significantly lower in patients that responded to treatment than in patients who did not (P < or = 0.027). Dose-limiting toxicities (gastrointestinal and myelosuppression) were seen with 500 and 600 mg/m(2) of cloretazine combined with the 4-day ara-C schedule but not seen with the 3-day schedule. CONCLUSION: The recommended cloretazine dose schedule for future studies is 600 mg/m(2) combined with 1.5 gm/m(2)/d continuous infusion of ara-C for 3 days. The cloretazine and ara-C regimen has significant antileukemic activity. AGT activity may be a predictor of response to cloretazine. 相似文献
94.
95.
96.
97.
98.
99.
Treatment of Rheumatoid Arthritis With Anti–Tumor Necrosis Factor or Tocilizumab Therapy as First Biologic Agent in a Global Comparative Observational Study 下载免费PDF全文
100.
Peri‐Conceptual and Mid‐Pregnancy Alcohol Consumption: A Comparison between Areas of High and Low Deprivation in Scotland 下载免费PDF全文